首页> 外文会议>Proceedings of international symposium on crystal engineering and drug delivery system 2009 >Enhanced Vascular Permeability in Solid Tumors and Tumor Targeted Delivery of Macromolecular Anticancer Drugs Based on EPR effect
【24h】

Enhanced Vascular Permeability in Solid Tumors and Tumor Targeted Delivery of Macromolecular Anticancer Drugs Based on EPR effect

机译:基于EPR效应的实体瘤血管通透性增强和大分子靶向抗肿瘤药物的肿瘤靶向递送

获取原文
获取原文并翻译 | 示例

摘要

@@Solid tumors are unique in their vascular anatomy which results in enhanced extravasations of macromolecules. In this context, the EPR (enhanced permeability and retention) effect in most solid tumors can be best utilized for selective tumor delivery of macromolecular polymeric drugs (1,2). It means not only passive drug targeting but also prolonged intratumoral drug retention is critically important for EPR effect. In addition to the microanatomical difference of tumor vasculature compared to the normal blood vessels, many vascular mediators are excessively generated in and vicinity of tumors such as nitric oxide, bradykinin, VEGF, prostacyclines, etc. They indeed facilitate the EPR effect. We have further developed methods to augment the EPR effect more. One method is to increase the drug delivery to tumor under elevated systolic blood pressure by infusing angiotensinⅡ(3). Anothor method to increase the tumor delivery is by use of nitroglycerin ointment (4). This is similar to the treatment of cardiac infarct or angina pectoris wherein hypoxic cardiac tissue is more selectively affected; This is also the case for many solid tumors. Namely, nitroglycerin is converted to nitrite in hypoxic state, and nitrite (NO2 -) is then reduced to nitric oxide (NO) in both tissues. NO not only affects vascular dilatation, it also facilitates vascular permeability, thus, augments the EPR effect. This nitroglycerin induced increase of tumor selective drug delivery, also augment the therapeutic effect of anthracycline and other polymeric anticancer agents (eg. PEG-ZnPP).
机译:固体肿瘤在其血管解剖学方面是独特的,这导致大分子外渗的增强。在这种情况下,在大多数实体瘤中的EPR(增强的通透性和滞留性)效果可以最好地用于大分子高分子药物的选择性肿瘤递送(1,2)。这意味着不仅是被动药物靶向,而且延长肿瘤内药物保留对于EPR效果至关重要。除了与正常血管相比,肿瘤血管的微观解剖学差异外,在肿瘤及其附近还大量生成许多血管介质,例如一氧化氮,缓激肽,VEGF,前列环素等。它们确实促进了EPR效应。我们进一步开发了进一步增强EPR效果的方法。一种方法是通过注入血管紧张素Ⅱ(3)来增加收缩压升高时向肿瘤的药物递送。通过使用硝酸甘油软膏来增加肿瘤的递送的另一种方法(4)。这类似于对心脏缺氧性心脏组织有更高选择性的心脏梗死或心绞痛的治疗。许多实体瘤也是如此。即,硝酸甘油在低氧状态下转化为亚硝酸盐,然后在两个组织中将亚硝酸盐(NO2-)还原为一氧化氮(NO)。 NO不仅影响血管扩张,还促进血管通透性,从而增强EPR作用。这种硝酸甘油诱导的肿瘤选择性药物递送的增加,还增强了蒽环类药物和其他聚合抗癌剂(例如PEG-ZnPP)的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号